 |
|
|
| |
DCV + ASV in IFN (± RBV) Ineligible/Intolerant Non-Japanese Asian Patients With Chronic HCV Genotype 1b Infection
|
| |
| |
Reported by Jules Levin
25th Conference of the Asian Pacific Association for the Study of the Liver:
APASL 2016, Tokyo, Japan
Wei L,1 Zhang MX,2 Xu M,3 Chuang WL,4 Lu W,5 Xie W,6 Jia ZS,7 Gong GZ,8 Li YQ,9 Bae SH,10 Yang YF,11 Xie Q,12 Lin SM,13 Chen XY,14 Niu JQ,15 Jia JD,16 Garimella T,17 Torbeyns A,18 McPhee F,19 Treitel M,17 Yin PD,19 Mo L20
1Peking University People's Hospital and Peking University Hepatology Institute, Beijing, China; 2Sixth People's Hospital of Shenyang, Shenyang, China; 3Guangzhou No.8 People's Hospital, Guangzhou, China; 4Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; 5Tianjin Second People's Hospital, Tianjin, China; 6Beijing Ditan Hospital, Capital Medical University, Beijing, China; 7Tangdu Hospital, Tangdu, China; 8The Second Xiangya Hospital of Central South University, Xiangya, China; 9302 Military Hospital of China, Beijing, China; 10Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea; 11The 2nd Hospital of Nanjing, Affiliated to Medical School of South East University, Nanjing, China; 12Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 13The First Affiliated Hospital of Xi'an Jiaotong University, Jiaotong, China; 14Beijing Youan Hospital, Capital Medical University, Beijing, China; 15First Hospital of Jilin University, Jilin, China; 16Beijing Friendship Hospital, Capital Medical University, Beijing, China; 17Bristol-Myers Squibb, Princeton, NJ, USA; 18Bristol-Myers Squibb, Braine-l'Alleud, Belgium; 19Bristol-Myers Squibb, Wallingford, CT, USA; 20Bristol-Myers Squibb, Shanghai, China
|
| |
|
|
|
|
|
